Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
AssigneePfizer Inc.
InventorsTimothy C. Thompson, Guang Yang, Michael G. Wyllie
Life of this patent
Estimating the term…
Abstract
A method for treating or preventing a BPH in a mammal which comprises administering to said mammal an amount of a drug, comprising an α1-adrenoreceptor antagonist or pharmaceutically acceptable acid addition salt thereof, effective for treating or preventing the BPH.
Claims20
A method for treating or preventing BPH in a mammal which comprises administering to said mammal an amount of a drug comprising an α1-adrenoreceptor antagonist, or pharmaceutically acceptable acid addition salt thereof, effective for treating or preventing the BPH.
A composition for treating or preventing a BPH in a mammal which comprises an amount of a drug comprising an α1-adrenoreceptor antagonist, or pharmaceutically acceptable acid addition salt thereof, effective for treating or preventing BPH for daily administration.
Dependencies are inferred from the claim text.